Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP591004.RAUgnB9JwizbTxlgs2AbnmxVKbXNBsf18LFz-keFBc-58130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP591004.RAUgnB9JwizbTxlgs2AbnmxVKbXNBsf18LFz-keFBc-58130_assertion type Assertion NP591004.RAUgnB9JwizbTxlgs2AbnmxVKbXNBsf18LFz-keFBc-58130_head.
- NP591004.RAUgnB9JwizbTxlgs2AbnmxVKbXNBsf18LFz-keFBc-58130_assertion description "[Using ectopically expressed dominant negative inhibitor, p100 mutant, and the siRNA approach, we demonstrate that selective inhibition of RelB significantly decreases the levels of MnSOD resulting in a significant increase in the sensitivity of prostate cancer cells to radiation treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591004.RAUgnB9JwizbTxlgs2AbnmxVKbXNBsf18LFz-keFBc-58130_provenance.
- NP591004.RAUgnB9JwizbTxlgs2AbnmxVKbXNBsf18LFz-keFBc-58130_assertion evidence source_evidence_literature NP591004.RAUgnB9JwizbTxlgs2AbnmxVKbXNBsf18LFz-keFBc-58130_provenance.
- NP591004.RAUgnB9JwizbTxlgs2AbnmxVKbXNBsf18LFz-keFBc-58130_assertion SIO_000772 16261162 NP591004.RAUgnB9JwizbTxlgs2AbnmxVKbXNBsf18LFz-keFBc-58130_provenance.
- NP591004.RAUgnB9JwizbTxlgs2AbnmxVKbXNBsf18LFz-keFBc-58130_assertion wasDerivedFrom befree-20150227 NP591004.RAUgnB9JwizbTxlgs2AbnmxVKbXNBsf18LFz-keFBc-58130_provenance.
- NP591004.RAUgnB9JwizbTxlgs2AbnmxVKbXNBsf18LFz-keFBc-58130_assertion wasGeneratedBy ECO_0000203 NP591004.RAUgnB9JwizbTxlgs2AbnmxVKbXNBsf18LFz-keFBc-58130_provenance.